HK1257584A1 - 預防和治療系統性硬化症的藥物及其用途 - Google Patents

預防和治療系統性硬化症的藥物及其用途

Info

Publication number
HK1257584A1
HK1257584A1 HK18116703.4A HK18116703A HK1257584A1 HK 1257584 A1 HK1257584 A1 HK 1257584A1 HK 18116703 A HK18116703 A HK 18116703A HK 1257584 A1 HK1257584 A1 HK 1257584A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
systemic sclerosis
treating systemic
treating
Prior art date
Application number
HK18116703.4A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257584A1 publication Critical patent/HK1257584A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116703.4A 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途 HK1257584A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257584A1 true HK1257584A1 (zh) 2019-10-25

Family

ID=62656674

Family Applications (5)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途
HK18116703.4A HK1257584A1 (zh) 2016-12-15 2018-12-28 預防和治療系統性硬化症的藥物及其用途
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18116708.9A HK1257589A1 (zh) 2016-12-15 2018-12-28 預防和治療組織器官纖維化的藥物及其用途
HK18116707.0A HK1257588A1 (zh) 2016-12-15 2018-12-28 預防和治療肺纖維化的藥物及其用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK18116704.3A HK1257585A1 (zh) 2016-12-15 2018-12-28 預防和治療皮膚纖維化的藥物及其用途
HK18116706.1A HK1257587A1 (zh) 2016-12-15 2018-12-28 預防和治療肝纖維化的藥物及其用途

Country Status (2)

Country Link
CN (5) CN108210910A (zh)
HK (5) HK1257589A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917335B (zh) * 2018-09-20 2023-06-27 华中科技大学同济医学院附属同济医院 Erdr1在预防和治疗纤维化疾病中的用途
US20230084586A1 (en) * 2020-02-06 2023-03-16 Talengen International Limited Method and drug for preventing and treating multiple sclerosis
CN115551534A (zh) * 2020-02-26 2022-12-30 泰伦基国际有限公司 一种预防和治疗血压异常病症的方法和药物
CN113925022A (zh) * 2021-10-22 2022-01-14 莫汉有 一种系统性红斑狼疮并动脉粥样硬化动物模型构建方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US20050250694A1 (en) * 2003-10-10 2005-11-10 Ma Jian-Xing Compounds useful in inhibiting vascular leakage, inflammation and fibrosis and methods of making and using same
AU2008331545B2 (en) * 2007-11-29 2014-01-16 Grifols Therapeutics Inc. Recombinantly modified plasmin
CN102482338B (zh) * 2009-07-10 2016-09-28 斯路姆基因公司 纤溶酶原和纤溶酶的变体
CN101628113B (zh) * 2009-08-18 2012-01-04 南京农业大学 蚯蚓纤溶酶抗肝纤维化的应用
US20120114652A1 (en) * 2010-05-03 2012-05-10 Abbott Laboratories Anti-pai-1 antibodies and methods of use thereof
WO2013134781A1 (en) * 2012-03-09 2013-09-12 Vascular Biosciences Orally active, cell-penetrating homing peptide and methods of using same
KR101467109B1 (ko) * 2013-07-10 2014-12-01 영남대학교 산학협력단 Ｂｉｘ02189 화합물을 유효성분으로 포함하는 폐섬유증 예방 또는 치료용 조성물
CN112142845A (zh) * 2013-08-13 2020-12-29 赛诺菲 纤溶酶原激活剂抑制剂-1(pai-1)的抗体及其用途
TW201722994A (zh) * 2013-08-13 2017-07-01 賽諾菲公司 胞漿素原活化素抑制劑-１（ｐａｉ-１）之抗體及其用途
US20160199466A1 (en) * 2013-08-20 2016-07-14 Trustees Of Dartmouth College Methods For Treating Tissue Fibrosis

Also Published As

Publication number Publication date
HK1257589A1 (zh) 2019-10-25
CN108210905A (zh) 2018-06-29
CN108210910A (zh) 2018-06-29
HK1257588A1 (zh) 2019-10-25
HK1257587A1 (zh) 2019-10-25
HK1257585A1 (zh) 2019-10-25
CN108210892A (zh) 2018-06-29
CN108210899A (zh) 2018-06-29
CN108210897A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
IL274162A (en) Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
IL290754A (en) Use of pyridofidine to treat anxiety and depression
IL290150A (en) Compounds and methods for treating chronic pain
HK1257584A1 (zh) 預防和治療系統性硬化症的藥物及其用途
IL265955A (en) Therapeutic compounds and methods of use thereof
HK1247963A1 (zh) 用於hiv的治療的基因療法及其用途
HK1257239A1 (zh) 預防和治療肥胖症的藥物及其用途
GB201617064D0 (en) Compounds and their therapeutic use
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
IL266486A (en) Pharmaceutical preparations and methods for cancer treatment
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1257586A1 (zh) 預防和治療腎纖維化的藥物及其用途
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
PT3519025T (pt) Dispositivo de administração
IL273863B1 (en) Hemorrhoid treatment device
RS65225B1 (sr) Lek za lečenje i/ili prevenciju endometrioze
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
PL3327201T3 (pl) Pojemnik i jego zastosowanie
GB201617715D0 (en) Methods for the treatment and prevention of ebola
GB201617591D0 (en) Methods for the treatment and prevention of ebola
GB201617590D0 (en) Methods for the treatment and prevention of ebola